Suppr超能文献

HR+/HER2-早期乳腺癌患者粗针穿刺活检后Ki-67变化模式与预后的相关性

Association of Ki-67 Change Pattern After Core Needle Biopsy and Prognosis in HR+/HER2- Early Breast Cancer Patients.

作者信息

Li Shuai, Chen Xiaosong, Shen Kunwei

机构信息

Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai China.

出版信息

Front Surg. 2022 Jun 28;9:905575. doi: 10.3389/fsurg.2022.905575. eCollection 2022.

Abstract

BACKGROUND

To investigate the association of Ki-67 change pattern after core needle biopsy (CNB) and prognosis in HR+/HER2- early breast cancer patients.

METHOD

Eligible patients were categorized into three groups: Low group, Elevation group, and High group. Chi-square test and logistic regression analysis were used to compare the clinic-pathological characteristics. Kaplan-Meier method was used to estimate the rates of recurrence-free interval (RFI) and breast cancer-specific survival (BCSS), which were compared the Log-rank test. Cox proportional hazard analysis was performed to investigate independent prognostic factors.

RESULTS

A total of 2,858 patients were included: 1,179 (41.3%), 482 (16.9%), and 1,197 (41.8%) patients were classified into the low, elevation, and high groups, respectively. Age, tumor size, histological grade, lymph-vascular invasion (LVI), and ER level status were associated with Ki-67 change pattern after CNB. With a median follow-up of 53.6 months, the estimated 5-year RFI rates for the low group, elevation, and high groups were 96.4%, 95.3% and 90.9%, respectively ( < 0.001). And 5-year BCSS rates were 99.3%, 98.3% and 96.8%, respectively ( = 0.001). Compared with patients in the low group, patients in the high group had significantly worse RFI (hazard ratio [] 1.71, 95% confidence interval [] 1.16-2.54) in multivariate analysis.

CONCLUSIONS

Ki-67 change after CNB was associated with prognosis in HR+/HER2- early breast cancer. Patients with Ki-67 high or elevation after CNB had an inferior disease outcome, indicating the necessity of re-evaluating Ki-67 on surgical specimens after CNB.

摘要

背景

探讨粗针穿刺活检(CNB)后Ki-67变化模式与HR+/HER2-早期乳腺癌患者预后的相关性。

方法

符合条件的患者分为三组:低组、升高组和高组。采用卡方检验和逻辑回归分析比较临床病理特征。采用Kaplan-Meier法估计无复发生存期(RFI)和乳腺癌特异性生存率(BCSS),并通过对数秩检验进行比较。进行Cox比例风险分析以研究独立预后因素。

结果

共纳入2858例患者:分别有1179例(4¹³%)、482例(16.9%)和1197例(41.8%)患者被分为低组、升高组和高组。年龄、肿瘤大小、组织学分级、淋巴管浸润(LVI)和雌激素受体(ER)水平状态与CNB后Ki-67变化模式相关。中位随访53.6个月,低组、升高组和高组的估计5年RFI率分别为96.4%、95.3%和90.9%(P<0.001)。5年BCSS率分别为99.3%、98.3%和96.8%(P=0.001)。多因素分析显示,与低组患者相比,高组患者的RFI明显更差(风险比[HR]1.71,95%置信区间[CI]1.16-2.54)。

结论

CNB后Ki-67变化与HR+/HER2-早期乳腺癌预后相关。CNB后Ki-67高或升高患者的疾病结局较差,提示CNB后对手术标本重新评估Ki-67的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3147/9275673/60e750b98a09/fsurg-09-905575-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验